Cannabis Report
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor, dr_lowenstein, NASDAQ2020, IB_, namtae, Chasing
Search This Board: 
Last Post: 6/18/2018 12:36:01 PM - Followers: 842 - Board type: Free - Posts Today: 41

Elite Pharmaceuticals, Inc. (ELTP)

 
About Elite Pharmaceuticals
 
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 
More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com
 


About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
 
Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
 
The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

ELTP Daily Chart
    


Cannabis Report
ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Current Report Filing (8-k) 06/14/2018 04:55:26 PM
ELTP News: Annual Report (10-k) 06/14/2018 04:40:16 PM
ELTP News: Current Report Filing (8-k) 06/14/2018 03:06:56 PM
ELTP News: Current Report Filing (8-k) 05/30/2018 04:07:01 PM
ELTP News: Current Report Filing (8-k) 05/29/2018 04:18:13 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#291665  Sticky Note Transcript for June, 15, 2018 Conference Call Chasing 06/15/18 07:13:27 PM
#290958  Sticky Note This is why I continue to buy monthly:) tedk10 06/08/18 02:46:23 PM
#288420  Sticky Note He cherry picked certain parts of the CRL stockboy 04/26/18 12:58:32 AM
#285485  Sticky Note I think you said in the past that no2koolaid 03/10/18 02:20:10 PM
#274770  Sticky Note memorable "calls" for elite pharma: dr_lowenstein 10/24/17 04:09:11 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#185967  Sticky Note The only topic here is ELTP. IH Dan (Retired) 02/23/16 09:32:46 PM
#291891   Hard to predict for most what price Elite namtae 06/18/18 12:36:00 PM
#291890   Probably have to wait and see if .056 stockboy 06/18/18 12:24:17 PM
#291889   Great support at $0.04. Might be a conix 06/18/18 12:22:31 PM
#291888   HAMMERTIME ELTP IS getting hammered DOWN AGAIN! stockboy 06/18/18 11:57:34 AM
#291887   The rush is on by buyers getting into conix 06/18/18 11:33:03 AM
#291886   Sure they are, just NO ONE believes it. stockboy 06/18/18 11:33:02 AM
#291885   2-3 Approvals Imminent. NASDAQ2020 06/18/18 11:31:17 AM
#291884   But all are YEARS away from APPROVAL! not stockboy 06/18/18 10:30:26 AM
#291883   Incorrect, We only had SequestOx NASDAQ2020 06/18/18 10:28:16 AM
#291882   Haha, still not at .02 and never will, kennyt 335 06/18/18 10:24:19 AM
#291881   Elite already found hammertime, about 2 years ago namtae 06/18/18 10:19:12 AM
#291880   You've been saying that for years. YET nastyRAT stockboy 06/18/18 10:17:28 AM
#291879   And it is coming, HAMMERTIME!:-) kennyt 335 06/18/18 10:15:18 AM
#291878   LMAO Elite is but an Approval or two away NASDAQ2020 06/18/18 10:12:48 AM
#291877   Yeah he know's burning through that $40 million stockboy 06/18/18 10:06:56 AM
#291876   CEO still taking shares in lieu of cash. NASDAQ2020 06/18/18 10:01:22 AM
#291875   I was told the same thing with SeaQuesTOX stockboy 06/18/18 09:50:50 AM
#291874   Sorry FDA only had one issue with SequestOx NASDAQ2020 06/18/18 09:50:31 AM
#291873   I only have to be right ONCE on NASDAQ2020 06/18/18 09:48:00 AM
#291872   LOL yeah didn't you hear the desperation in stockboy 06/18/18 09:46:55 AM
#291871   Yea, the FDA is plotting against Elite... no namtae 06/18/18 09:42:36 AM
#291870   Sure the FDA will prevent anything from happening stockboy 06/18/18 09:39:36 AM
#291869   Elite’s Avatar will prevent that from happening. NASDAQ2020 06/18/18 09:36:30 AM
#291868   OH YEAH $trillion markets, but all he can stockboy 06/18/18 09:33:10 AM
#291867   The Next Avatar will be SunGen #3 it’s NASDAQ2020 06/18/18 09:28:19 AM
#291866   I know but they will be years away stockboy 06/18/18 09:27:49 AM
#291865   Won’t be necessary NASDAQ2020 06/18/18 09:25:44 AM
#291864   Probably sitting around playing tiddly winks.! stockboy 06/18/18 08:59:32 AM
#291863   But 0 pathways to .10 stockboy 06/18/18 08:57:52 AM
#291862   RIGHT and how many years and CRL's will stockboy 06/18/18 08:57:04 AM
#291861   After the reverse split! stockboy 06/18/18 08:56:13 AM
#291860   6 ANDAs filed one is NASDAQ2020 06/18/18 07:36:15 AM
#291859   If the CEO suddenly isnt playing around now.... namtae 06/18/18 07:30:55 AM
#291858   Yep!!! Patent was filed last week!!! aELmTPa 06/18/18 07:28:39 AM
#291857   Nasrat also getting patent filed for the NEW NASDAQ2020 06/18/18 07:24:16 AM
#291856   Short interest declining. NASDAQ2020 06/18/18 07:19:26 AM
#291855   The confidence Nasrat has in Elite is just aELmTPa 06/18/18 07:16:01 AM
#291854   21 Roads to DollarLand NASDAQ2020 06/18/18 07:09:29 AM
#291853   No approvals, just more BS from the ceo In namtae 06/18/18 06:41:11 AM
#291852   We have two bigger drugs that will be NASDAQ2020 06/18/18 06:32:25 AM
#291851   When this going to hit .25 again?? tmeier 06/18/18 03:03:08 AM
#291850   Investors care. mrwrn2010 06/17/18 11:10:58 PM
#291849   Slam dunk got rejected. jour_trader 06/17/18 11:05:49 PM
#291848   I heard years ago it was 98% GUARANTEED stockboy 06/17/18 10:52:40 PM
#291847   Some buy because they love supporting NasRAT's dilution machine. stockboy 06/17/18 10:51:18 PM
#291846  Restored What's scary is nasRAT keeps dangling new carrots stockboy 06/17/18 10:50:00 PM
#291845   What's scary is nasRAT keeps dangling new carrots stockboy 06/17/18 10:49:59 PM
#291844   WOW a WHOLE $6500 that will make UN-elite stockboy 06/17/18 10:44:58 PM
#291843   What was the statistical likelihood that SequestOx would jour_trader 06/17/18 10:18:20 PM
#291842   Approvals mean very little. NASDAQ2020 06/17/18 09:38:30 PM
PostSubject